公司资料
Nanobiotix 股价、新闻与催化剂
- 股票代码:
- NBTX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- France and listed in the U
股票表现
43.68 USD (-3.77%)
收盘价
最后更新: 2026年8月20日
1.86B USD
市值
股价为何变动
As of Aug 20, 2026, NBTX closed down 3.77% at $43.68. No new same-company headline was identified in the current news window.
公司概览
业务概览
Nanobiotix is a radiotherapy and oncology company focused on nanoparticle-enabled cancer treatment. Its platform is built around improving how radiation interacts with tumors.
所在地与行业分类
Headquartered in France and listed in the U.S. as an ADR, Nanobiotix has a global oncology-biotech profile.
商业模式特征
The business depends on clinical data, regulatory progress, and the ability to translate nanoparticle science into cancer value.
生物医药行业定位
Nanobiotix is a catalyst-driven oncology name whose stock reacts strongly to development and partnership updates.
未来催化剂
- Nanobiotix’s catalysts are its radioenhancer platform and any oncology update that shows the technology can improve local control without unacceptable toxicity. The market will care about whether the platform continues to look clinically relevant.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。